Skip to content

Arrhythmias in Myotonic Muscular Dystrophy

A Registry of Arrhythmias in Myotonic Muscular Dystrophy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00622453
Acronym
DM1
Enrollment
448
Registered
2008-02-25
Start date
1996-09-30
Completion date
2015-02-28
Last updated
2018-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmia, Muscular Dystrophy, Sudden Cardiac Death

Brief summary

Adult myotonic muscular dystrophy (Steinert's disease) is the most common inherited neuromuscular disorder. Cardiac rhythm disturbances occur frequently in this disease state and may be responsible for up to one-third of deaths. In this study, we intend to evaluate the utility of non-invasive electrocardiographic screening methods and history in predicting serious arrhythmic events.

Detailed description

The long term objectives of this population study is a more defined natural history, optimal diagnostic testing methodology, and methods of therapy for arrhythmias in individuals with myotonic muscular dystrophy. The goal is a more adequate definition of appropriate diagnosis and therapy for arrhythmias in order to decrease the likelihood of cardiac morbidity and mortality in this disorder. The specific aims of the study involve an initial survey of individuals with myotonic muscular dystrophy detailing multiple factors. Non-invasive electrocardiographic testing will be done. Using this initial data and subsequent follow-up data collected yearly the cohort of patients will be followed as to arrhythmia development over a minimum of five years and likely longer with a long-term registry and evaluation of National Death Records and Ancestry.com. This project is unique in that it characterizes a non-neurologic abnormality associated with a neuromuscular disease, myotonic muscular dystrophy.

Interventions

OTHERScreening

Electrocardiography Blood Test

Sponsors

Muscular Dystrophy Association
CollaboratorOTHER
Indiana University School of Medicine
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age 18 and over 2. Willing to sign informed consent 3. Have a previous diagnosis of myotonic muscular dystrophy

Exclusion criteria

1. Under age 18. 2. Unwilling to sign consent. 3. Unwilling to commit to long-term follow-up.

Design outcomes

Primary

MeasureTime frame
Evaluate incidence of arrhythmias in myotonic muscular dystrophy3 years

Secondary

MeasureTime frame
Evaluate with diagnostic non-invasive electrocardiogram (ECG)3 Years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 5, 2026